Postprandial hyperglycemia (PPHG) is primarily due to aboriginal appearance insulin secretion. Alpha glucosidase inhibitors adjournment glucose assimilation at the civil akin and thereby anticipate abrupt billow of glucose afterwards a meal.
There are three drugs which accord to this class, acarbose, miglitol and voglibose, of which voglibose is the newest. Voglibose array over both acarbose and miglitol in agreement of ancillary aftereffect profile. But acarbose has an bend over voglibose in agreement of ability (FPG, PPHG, HBA1c).
There are several trials acknowledging the use of voglibose in the administration of PPHG. Also, it has been accustomed that it is PPHG, not FPG, which is the brand of cardiovascular disorders associated with diabetes. So, authoritative PPHG is acute and voglibose is adumbrated for the administration of PPHG.
Voglibose marketed in India as "Prevog" by Zydus Cadila.
More about: Voglibose sale
From: pharma products